Cell Death and Disease· 2016Q1· Review
Mesenchymal stem cells and immunomodulation: current status and future prospects
- 1,159citations
- Q1SCImago
- 2016year
Short summary
Mesenchymal stem cells (MSCs) show promise for treating inflammatory and autoimmune disorders due to their unique immunomodulatory properties, but widespread clinical application faces challenges.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Genetics
GeneticsMedicine